Skip to content
  1. Home/
  2. Latest news/
  3. What you need to know about Johnson & Johnson’s 2021 fourth-quarter and full-year earnings report
A cartoon illustration of pie, bar and other graphs

What you need to know about Johnson & Johnson’s 2021 fourth-quarter and full-year earnings report

Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Consumer Health, Pharmaceutical and Medical Devices businesses.

fourth-quarter-and-full-year-earnings-banner-0122.png

Today, Johnson & Johnson shared its 2021 fourth-quarter and full-year earnings report.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 136,000 employees across the globe working every day to help change the trajectory of health for humanity.

Johnson & Johnson’s strong 2021 fourth-quarter and full-year results were driven by the relentless agility, resilience and commitment of our global colleagues,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We are well-positioned for the year ahead with a continued focus on optimizing our core businesses and investing in a robust pipeline of breakthrough innovations across the enterprise.”

For more details about the company’s 2021 fourth-quarter and full-year results, and to read a message from Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.


Johnson & Johnson EOY Q4 2021 Earnings infographic

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.